Check this article for a quick review on ovarian cancer research and ovarian cancer clinical trials.
Ovarian Cancer Research trials are being carried out to see whether ovarian cancers can be detected early so that they can be treated more effectively.
What is screening? This includes the ovarian cancer research trials, testing women who have no symptoms of ovarian cancer, to see if testing can detect the cancer at an early stage.
Currently it is not known whether screening can help to detect ovarian cancers at an earlier stage, so there is no national screening program for ovarian cancer in the UK.
Women who may have an increased risk of ovarian cancer can ask their doctors to carry out regular tests for ovarian cancer as part of a research trial.
Research! Note that all treatments have to be fully researched before they can be adopted as standard treatment for everyone. This is so that to be sure they work better than the treatments that are available at the moment. That’s what research all about. They are known to be safe.
First of all, treatments are developed and tested in laboratories. For ethical and safety reasons, experimental treatments must be tested in the laboratory before they can be tried in patients.
Good News! Non-profit foundation are available that raise funds for cutting-edge medical research in the women’s healthcare field.
Heard of Clinical Trials? These clinical trials are used on patients by specialists to produce better recovery rates in the treatment methods. There are many clinical trials implemented, some of them are as follows:
Trial 1: Familial ovarian cancer registers (FOCR)
Family History! Yes, this is an important risk factor for ovarian cancer. This could be due to inherited genetic faults in genes.
In this study, the ovarian cancer research team will record information about families where at least 2 relatives have or had ovarian cancer. The aim of the study is to find out more information about the causes of ovarian cancer. And perhaps find a way to help prevent ovarian cancer in the future.
Trial 2: The use of CA 125 blood test to help monitor women with advanced ovarian cancer
Trial 3: A study to see if cell changes can help doctors tell who will respond well to chemotherapy for ovarian cancer (DNA methylation study)
Trial 4: Same dose or increasing dose of carboplatin for ovarian cancer, fallopian tube cancer or primary peritoneal cancer (SCOTROC 4).
Trial 5: Chemotherapy before or after surgery for women with advanced ovarian, peritoneal or fallopian tube cancer (EORTC 55971)
Trial 6: A trial looking at combretastatin and chemotherapy for advanced ovarian cancer, primary peritoneal cancer, and fallopian tube cancer (CA4P-UKCTC-207)
Trial 7: Growth factor inhibitor, BIBF 1120, for fallopian tube cancer, peritoneal cancer and advanced ovarian cancer. The aim of this trial is to find out how well BIBF 1120 works.
Combretastatin is a new treatment. This process involves the swelling up of cells that line the cancer’s tiny blood vessels or capillaries. These swollen cells block the blood flow to the cancer cells.
All cancers need a blood supply so that they can get the oxygen and food they need to survive. Doctors hope that if they can block the blood supply, they can stop the cancer growing.
The aim of this ovarian cancer clinical trial is to find out how well CA4P, carboplatin and paclitaxel work together. The researchers of the ovarian cancer research team will also monitor the side effects of this combination of treatments [Ovarian Cancer Treatment].
Oops! Lot of medical terminology isn’t it. But to be aware of how ovarian cancer research goes on about each and every aspect, just to reach a common goal, to provide a better treatment option for the ovarian cancer patients, to know its exact cause and the preventive measures, one can follow is the most important of all.